NOVA IVF Fertility witnesses over 30k new couples

6 122
Representational Image

Misbah Ali

After one and a half years of the pandemic, people have learned to lead their lives in the new normal. Couples who were postponing their fertility treatments due to rising COVID cases and lockdowns, are now moving towards achieving their dream of becoming parents—and have resumed their fertility assessments and treatments.

Apart from the already existing ones, over 30,000 new couples have come forth for their fertility assessment and In vitro fertilization (IVF) treatments from Nova IVF Fertility Clinic.

Over 100 couples who contracted the virus have resumed their treatment post-recovery, and out of these, 40 couples have already undertaken the journey of conception after successful fertility treatments at Nova IVF.

Talking about the aim to increase and improve the accessibility of fertility treatments to every couple in India, CEO of Nova IVF Fertility, Shobhit Agarwal said, “As one of India’s leading IVF chains we believe in the utmost safety of our patients. With all our 35 centres following COVID appropriate behaviour and almost all our employees vaccinated, we aim to increase and improve the accessibility of fertility treatments to every couple in India, who is aspiring for parenthood.”

“Couples are now coming to the realisation that the pandemic is here to stay, and fertility treatments are time-sensitive procedures and should not be postponed. We are witnessing a surge across all our centres and see a massive demand coming from tier 2 markets as well. At Nova IVF Fertility, we have witnessed 65 per cent of positive pregnancies amongst the couples with over 2,000 live births and still counting during the pandemic,” he further added.

In 2018, India’s IVF services market was valued at $478.2 million. It is estimated to reach $1,453.0 million by 2026, registering a CAGR of 14.7 per cent during the analysis period.


  1. Be first to post your comments

Your Comment

Your email address will not be published. Required fields are marked *


Drug Today Medical Times

Back to Top